Cutting-edge discoveries in hepatitis, liver transplants, and genetic liver disease to be revealed at National Medical Conference
DALLAS, TEXAS – The nation’s leading biomedical researchers will present breakthrough therapies and technologies in liver disease October 29 through October 31 at the 51st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), the leading medical organization dedicated to the study of the liver and its diseases.
AASLD encourages the media to attend the more than 1,200 presentations covering liver-related diseases featuring previously-unpublished findings on such diverse topics as:
- Genetically-determined alcoholic liver disease
- Therapeutic liver regeneration with pancreatic cells and bone marrow stem cells
- The role of viral infection in the development of primary biliary cirrhosis
- Liver cancer emerging as a frequent consequence of chronic viral hepatitis
A pressroom will be available for media representatives in the Wyndham Anatole Hotel, Dallas, Texas, on Sunday, October 29 through Tuesday, October 31, daily from 8:00 a.m. to 6:00 p.m. at 214-761-2984.
For copies of abstracts, abstract summary highlights and press releases, to arrange for pre-conference researcher interviews, or to pre-register for onsite press credentials, contact Devon Ramirez at: 202-331-0175, devon@kmcpr.com
To view abstracts online go to: http://aasld00.agora.com/grader/lookup.asp
AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD’s vision is to prevent and cure liver diseases. Today, AASLD provides representation and education for nearly 2,400 liver researchers, physicians, and surgeons worldwide. Visit AASLD’s website at: http://www.aasld.org